Vanguard Group’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $761M | Sell |
4,164,818
-15,828
| -0.4% | -$2.21M | 0.01% | 838 |
|
|
2025
Q3 | $508M | Buy |
4,180,646
+235,626
| +6% | +$26.5M | 0.01% | 1059 |
|
|
2025
Q2 | $412M | Buy |
3,945,020
+68,078
| +2% | +$7.21M | 0.01% | 1129 |
|
|
2025
Q1 | $452M | Sell |
3,876,942
-25,537
| -0.7% | -$2.91M | 0.01% | 1048 |
|
|
2024
Q4 | $330M | Sell |
3,902,479
-92,866
| -2% | -$8.54M | 0.01% | 1284 |
|
|
2024
Q3 | $359M | Buy |
3,995,345
+253,343
| +7% | +$22.1M | 0.01% | 1222 |
|
|
2024
Q2 | $301M | Buy |
3,742,002
+1,724
| +0% | +$128K | 0.01% | 1258 |
|
|
2024
Q1 | $298M | Buy |
3,740,278
+43,512
| +1% | +$3.65M | 0.01% | 1281 |
|
|
2023
Q4 | $294M | Sell |
3,696,766
-32,360
| -0.9% | -$2.16M | 0.01% | 1299 |
|
|
2023
Q3 | $261M | Sell |
3,729,126
-13,627
| -0.4% | -$1.02M | 0.01% | 1295 |
|
|
2023
Q2 | $269M | Buy |
3,742,753
+257,003
| +7% | +$19M | 0.01% | 1307 |
|
|
2023
Q1 | $215M | Buy |
3,485,750
+68,122
| +2% | +$4.48M | 0.01% | 1413 |
|
|
2022
Q4 | $264M | Buy |
3,417,628
+306,128
| +10% | +$18.3M | 0.01% | 1266 |
|
|
2022
Q3 | $139M | Buy |
3,111,500
+309,362
| +11% | +$15.5M | ﹤0.01% | 1604 |
|
|
2022
Q2 | $107M | Buy |
2,802,138
+102,648
| +4% | +$3.25M | ﹤0.01% | 1778 |
|
|
2022
Q1 | $112M | Buy |
2,699,490
+13,868
| +0.5% | +$430K | ﹤0.01% | 1877 |
|
|
2021
Q4 | $101M | Buy |
2,685,622
+28,737
| +1% | +$1.06M | ﹤0.01% | 1975 |
|
|
2021
Q3 | $87.6M | Buy |
2,656,885
+42,740
| +2% | +$1.67M | ﹤0.01% | 2055 |
|
|
2021
Q2 | $176M | Buy |
2,614,145
+10,405
| +0.4% | +$624K | ﹤0.01% | 1695 |
|
|
2021
Q1 | $147M | Sell |
2,603,740
-37,334
| -1% | -$2.63M | ﹤0.01% | 1740 |
|
|
2020
Q4 | $215M | Buy |
2,641,074
+52,163
| +2% | +$3.9M | 0.01% | 1429 |
|
|
2020
Q3 | $184M | Buy |
2,588,911
+655,351
| +34% | +$51.1M | 0.01% | 1333 |
|
|
2020
Q2 | $159M | Buy |
1,933,560
+539,754
| +39% | +$41.5M | 0.01% | 1420 |
|
|
2020
Q1 | $82M | Buy |
1,393,806
+31,862
| +2% | +$2.6M | ﹤0.01% | 1638 |
|
|
2019
Q4 | $141M | Buy |
1,361,944
+102,689
| +8% | +$4.15M | ﹤0.01% | 1580 |
|
|
2019
Q3 | $25.5M | Buy |
1,259,255
+106,970
| +9% | +$2.75M | ﹤0.01% | 2365 |
|
|
2019
Q2 | $29.7M | Buy |
1,152,285
+250,498
| +28% | +$5.02M | ﹤0.01% | 2343 |
|
|
2019
Q1 | $12.8M | Buy |
901,787
+563,083
| +166% | +$5.23M | ﹤0.01% | 2691 |
|
|
2018
Q4 | $955K | Sell |
338,704
-233,997
| -41% | -$770K | ﹤0.01% | 3575 |
|
|
2018
Q3 | $1.98M | Sell |
572,701
-7,904
| -1% | -$23.4K | ﹤0.01% | 3534 |
|
|
2018
Q2 | $1.86M | Buy |
580,605
+46,926
| +9% | +$145K | ﹤0.01% | 3520 |
|
|
2018
Q1 | $1.31M | Buy |
533,679
+43,927
| +9% | +$132K | ﹤0.01% | 3585 |
|
|
2017
Q4 | $2.74M | Buy |
489,752
+69,830
| +17% | +$353K | ﹤0.01% | 3329 |
|
|
2017
Q3 | $2.33M | Buy |
419,922
+143,307
| +52% | +$769K | ﹤0.01% | 3356 |
|
|
2017
Q2 | $1.52M | Sell |
276,615
-58,130
| -17% | -$243K | ﹤0.01% | 3462 |
|
|
2017
Q1 | $1.3M | Buy |
334,745
+62,556
| +23% | +$299K | ﹤0.01% | 3513 |
|
|
2016
Q4 | $1.84M | Buy |
272,189
+18,440
| +7% | +$130K | ﹤0.01% | 3383 |
|
|
2016
Q3 | $2M | Buy |
253,749
+5,812
| +2% | +$44K | ﹤0.01% | 3395 |
|
|
2016
Q2 | $1.87M | Buy |
247,937
+39,513
| +19% | +$364K | ﹤0.01% | 3404 |
|
|
2016
Q1 | $1.79M | Buy |
+208,424
| New | +$1.91M | ﹤0.01% | 3423 |
|
Other funds holding AXSM
DTC
NAMI
RI